Childhood cancers trials in China

In China 609 Also abroad 2483

609 trials · From ClinicalTrials.gov, checked 14 November 2026. Ask the study team whether a trial fits you.

Phase 1Taking people
A Clinical Study to Evaluate the Safety, Tolerability, and Preliminary Efficacy of B019 Injection in Subjects With Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia.
Where
Beijing, Nanchang, Shanghai, Suzhou, Wuhan, Xuzhou
Age
3 years to 25 years
People
33
Run by
Shanghai Pharmaceutical Group Biological Therapy Technology Co., Ltd.
See details and how to joinNCT06927466
Phase 2Taking people
Omission of Adjuvant Radiotherapy in Young Low-Risk Ductal Carcinoma In Situ Following Breast-Conserving Surgery
Where
Shanghai
Age
Up to 40 years
People
234
Run by
Fudan University
See details and how to joinNCT07762924
No phaseTaking people
Intermediate-dose HAD Regimen for CEBPA Double-mutated AML
Where
Tianjin
Age
14 years to 54 years
People
148
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06529250
No phaseTaking people
MRD-positive AML Clinical Study
Where
Tianjin
Age
14 years and over
People
537
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07131059
Phase 1Taking people
Metformin Inhibits DNMT3A Clonal Hematopoiesis in Acute Leukemia
Where
Tianjin
Age
14 years and over
People
32
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07188740
No phaseTaking people
Pediatric-Inspired Regimen Combined With Venetoclax and Immunotherapy for Adult Ph-Negative Acute Lymphoblastic Leukemia
Where
Tianjin
Age
14 years to 60 years
People
43
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07495631
No phaseTaking people
Multicenter, Platform-type Clinical Study of Refractory/Recurrent Acute Myeloid Leukemia
Where
Tianjin
People
458
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06265545
Phase 3Taking people
Standard-dose vs Intermediate-dose Cytarabine Induction in the Treatment of Acute Myeloid Leukemia With RUNX1-RUNX1T1
Where
Tianjin
Age
14 years to 60 years
People
284
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06744504
No phaseTaking people
Venetoclax, Azacitidine and Liposomal Mitoxantrone for Newly Diagnosed AML
Where
Tianjin
Age
14 years to 100 years
People
27
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07490288
No phaseNot yet taking people in China
Plasma ctDNA Monitoring in Pediatric Acute Leukemia
Where
Tianjin
Age
3 years to 18 years
People
25
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07751588
No phaseTaking people
Venetoclax TDM in Newly Diagnosed AML: Exposure-Response and Prognosis
Where
Suzhou
Age
16 years and over
People
50
Run by
The First Affiliated Hospital of Soochow University
See details and how to joinNCT07670130
No phaseNot yet taking people in China
Effects of a Large Language Model-Driven Chatbot on Reproductive Concerns After Cancer
Where
Hefei
Age
15 years to 39 years
People
60 worldwide
Run by
The Hong Kong Polytechnic University
See details and how to joinNCT07741266
No phaseNot yet taking people in China
Clinical Application Value of Deep Learning-Based "Opportunistic Screening" for Malignant Tumors on Routine Non-Contrast Chest-Abdomen-Pelvis CT
Where
Wuhan
People
100,000
Run by
Lian Yang
See details and how to joinNCT07639567
Phase 2Taking people
Orelabrutinib Plus Lisaftoclax and Rituximab in Untreated Mantle Cell Lymphoma With High-Risk Disease
Where
Shanghai
Age
14 years and over
People
25
Run by
Ruijin Hospital
See details and how to joinNCT07272499
Phase 3Taking people
Phase III Clinical Study of VC004 in Patients With Localized Advanced/ Metastatic Solid Tumors
Where
Beijing
Age
12 years and over
People
54
Run by
Jiangsu vcare pharmaceutical technology co., LTD
See details and how to joinNCT06658353
No phaseEnrolling by invitation
Comparison of the Effect of Surgical Resection Based on Lesion Extent Before and After Neoadjuvant Therapy in Patients With Stage II-IIIB Non-Small Cell Lung Cancer: A Single-Center, Real-World, Open-Label Study
Where
Beijing
People
354
Run by
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07373899
Phase 2Taking people
Phase II Study of QLC2519 in Pediatric Solid Tumor Participants
Where
Beijing
Age
0 years to 18 years
People
18
Run by
Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT07724756
No phaseTaking people
Prospective Evaluation of Dynamic Serum ProGRP for Treatment Response Monitoring in Ewing Sarcoma
Where
Beijing
Age
10 years to 60 years
People
100
Run by
Peking University People's Hospital
See details and how to joinNCT07725783
Phase 3Taking people
A Study of Olverembatinib in SDH-deficient GIST.
Where
Guangzhou
Age
12 years and over
People
40
Run by
Ascentage Pharma Group Inc.
See details and how to joinNCT06640361
Phase 2/3Taking people
Newly-diagnosed Intermediate/High Risk Pediatric B-cell ALL Protocol
Where
Changsha, Chengdu, Chongqing, Fuzhou, Guangzhou, Guiyang, Hefei, Jinan, Nanchang, Nanjing, Nanning, Qingdao, Shanghai, Shenzhen, Suzhou, Tianjin, Wuhan, Xi’an
Age
1 month to 18 years
People
1,800 worldwide
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT06764238
No phaseTaking people
Chemotherapy With Targeted-Immunotherapy for Newly Diagnosed Ph+ ALL
Where
Tianjin
Age
14 years and over
People
110
Run by
Institute of Hematology & Blood Diseases Hospital, China
See details and how to joinNCT07493161
No phaseTaking people
Development of an AI-Agent for Urological Disease Diagnosis and Treatment
Where
Ganzhou, Guangzhou, Shantou
People
2,000
Run by
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT07721935
No phaseTaking people
MRI-DTI Assessment of Urethral Internal Sphincter Ring and Prostate Base Morphology
Where
Taizhou
Age
15 years to 90 years
People
80
Run by
Jiangsu Taizhou People's Hospital
See details and how to joinNCT07694752
Phase 2Not yet taking people in China
Platform Research for Innovative Medicines in NF2-SWN (PRIME-NF2)
Where
Beijing, Changchun, Shanghai
People
200
Run by
Beijing Tiantan Hospital
See details and how to joinNCT07713745
Phase 2Not yet taking people in China
Orlistat Plus Progestin for Fertility-Sparing Treatment of Endometrial Cancer or Atypical Hyperplasia
Where
Beijing
Age
Up to 46 years
People
48
Run by
Peking University People's Hospital
See details and how to joinNCT07714070